ALB and cancer: Liu et al. [51] showed that combined circulating dNLR and Alb was an effective diagnostic biomarker for early stage PC (AUC = 0.931), and that dNLR could distinguish early-stage PC from HC (AUC 0.895) and from additional cancers (AUC 0.794).